Although this did not reach statistical significance, there was a small rise in serum sclerostin (555 pg/mL at baseline to 648 pg/mL and 595 pg/mL at 6 and 24 weeks, respectively, p = 0.092, Fig. 1 D ) and serum IL‐6 (1.09 pg/mL at baseline to 1.80 g/mL and 1.58 pg/mL at 6 and 24 weeks respectively, p = 0.076, Fig. 1 E ).
← all excerpts
Androgen Deprivation Therapy Differentially Impacts Bone and Muscle in the Short Term in Physically Active Men With Prostate Cancer.
1
0.0920
0.0920